We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$14.3B
AUM Growth
-$743M
Cap. Flow
-$499M
Cap. Flow %
-3.49%
Top 10 Hldgs %
8.41%
Holding
1,329
New
83
Increased
398
Reduced
492
Closed
75

Top Sells

Rank Stock Value
1
MKSI icon
MKS Inc
MKSI
+$35.5M
2
WWD icon
Woodward
WWD
+$35M
3
CPRT icon
Copart
CPRT
+$22.9M
4
BGC
General Cable Corporation
BGC
+$22.7M
5
ORBK
Orbotech Ltd
ORBK
+$22.1M

Sector Composition

Rank Sector Weight
1 Industrials 29.72%
2 Technology 18.26%
3 Consumer Discretionary 14.92%
4 Financials 12.29%
5 Materials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBC
1326
DELISTED
Flagstar Bancorp, Inc. New
FBC
-329
Closed -$12K
RAS
1327
DELISTED
RAIT Financial Trust
RAS
$0 ﹤0.01%
1
PGEM
1328
DELISTED
Ply Gem Holdings, Inc.
PGEM
-559,911
Closed -$10.4M
SNBC
1329
DELISTED
Sun Bancorp Inc
SNBC
-355
Closed -$9K

Similar funds

Royce & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Royce & Associates held 1,329 positions worth $14.3B, down 4.9% from $15B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Royce & Associates withdrew a net $499M in Q1 2018, closing 75 positions and reducing 492 holdings. Its most notable exit was Sucampo Pharmaceuticals, Inc., an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in PotlatchDeltic worth $12M.

  • Royce & Associates's largest Q1 2018 buy was PotlatchDeltic: 230,008 shares worth $12M.
  • Royce & Associates added most to Core Mark Holding Co., Inc. in Q1 2018, an estimated $24M increase.
  • Royce & Associates's biggest Q1 2018 reduction was MKS Inc, cutting an estimated $35.5M.
  • Royce & Associates fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $15.8M.
  • Royce & Associates's ten largest holdings make up 8.4% of its $14.3B portfolio in Q1 2018.
  • Royce & Associates opened 83 new positions and closed 75 in Q1 2018.
  • Royce & Associates's portfolio value fell 4.9% quarter-over-quarter to $14.3B.

Based on Royce & Associates's 13F filing for Q1 2018, filed 14 May 2018.